Lionheart III Corp (LION) Peer Comparison
$11.16
$-0.09
(-0.80%)
As on 02-Oct-2026 16:00EDT
Market cap
$3,321 Mln
Revenue (TTM)
$2,883 Mln
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
Edit
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
3,321 | 5,286 | 668 | 482 | 441 |
Revenue ($ Mln) |
2,883 | 440 | -- | -- | 330 |
Net Profit ($ Mln) |
-118.30 | -1,435.01 | -134.20 | 3.04 | 100.20 |
Net Margin (%) |
-4.10 | -325.91 | -- | -- | 30.33 |
RoE (%) |
-- | -- | -40.17 | 2.34 | 30.44 |
Price to Earnings |
-- | -- | -- | -- | 4.62 |
Price-To-Book |
1.35 | -- | -- | -- | 1.27 |
Income Statement ($ Mln)
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
2,631.80 | 319.02 | -- | -- | 335.44 |
|
Cost of Revenue
|
1,584.40 | 281.12 | -- | -- | 46.04 |
|
Gross Profit
|
1,047.40 | 37.90 | -- | -- | 289.40 |
|
Operating Expenses
|
899.40 | 262.45 | 0.17 | 0.44 | 146.67 |
|
Operating Profit (EBIT)
|
148.00 | -224.55 | -0.17 | -0.44 | 142.73 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-159.30 | -288.03 | 0.38 | 1.83 | 142.73 |
|
Provision for Tax
|
16.20 | 0.58 | -- | -- | 35.94 |
|
Profit after Tax (Net Income)
|
-198.30 | -288.62 | 0.38 | 1.83 | 106.84 |
|
Minority Interest
|
143.50 | -- | -- | -- | 0.00 |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-1,276.40 | -962.74 | 399.79 | 256.62 | 317.57 |
|
Minority Interest
|
143.50 | -- | -- | -- | 0.00 |
|
Non-Current Liabilities
|
3,507.00 | 2,528.98 | 15.99 | 256.91 | 160.23 |
|
Current Liabilities
|
2,868.70 | 781.40 | 0.13 | 0.29 | 594.94 |
|
Total Liabilities
|
5,244.20 | 2,347.64 | 415.91 | 255.27 | 1,072.73 |
Assets ($ Mln)
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
3,924.70 | 1,452.11 | 414.85 | 510.64 | 349.32 |
|
Current Assets
|
1,319.50 | 895.54 | 1.06 | 255.27 | 723.41 |
|
Total Assets
|
5,244.20 | 2,347.64 | 415.91 | 255.27 | 1,072.73 |
|
Total Debt*
|
3,975.30 | 1,060.33 | -- | -- | 152.49 |
|
Net Current Assets
|
-1,558.20 | 114.14 | 0.93 | 2.88 | -- |
Cashflow ($ Mln)
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
24.80 | 278.25 | -0.63 | -- | 71.03 |
|
Cash Flow from Investing Activities
|
-12.20 | -740.75 | -414.00 | -- | 0.62 |
|
Cash from Financing Activities
|
114.30 | -63.10 | 415.37 | -- | -1.08 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-7.47 | -120.97 | -- | -- | 24.90 |
|
ROE (%)
|
17.08 | 32.38 | -- | -- | 38.62 |
|
ROA (%)
|
-3.83 | -14.63 | -- | -- | 9.34 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-7.53 | -90.47 | -- | -- | 31.85 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.18 | -0.38 | -- | -- | 0.13 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-54.32 | 78.05 | -- | -- | 41.10 |
|
EPS Growth (%)
|
-0.54 | 0.80 | -- | -- | 0.40 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-13.35 | -19.80 | -- | -- | 5.90 |
|
Price / Book Value
|
-2.07 | -5.94 | -- | -- | 1.99 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
5.65 | -31.10 | -- | -- | 2.71 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-3.11 | -1.10 | -- | -- | 0.48 |
|
Short term debt to equity ratio
|
-1.08 | -0.03 | -- | -- | 0.00 |
|
Current Ratio
|
0.46 | 1.15 | 8.13 | 892.48 | 1.22 |
|
Quick Ratio
|
-- | -- | -- | -- | -- |
|
Interest Coverage
|
0.39 | -87.90 | -- | -- | 14.20 |
Operating Efficiency Ratios
| Lionheart III Corp (LION) | Core Scientific Inc (CORZ) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
29.34 | 105.69 | -- | -- | 61.95 |
|
Asset Turnover
|
0.51 | 0.16 | -- | -- | 0.29 |
|
Receivable days
|
125.70 | 193.60 | -- | -- | 281.90 |
|
Inventory Days
|
-5.88 | -5.77 | -- | -- | -1,881.69 |
|
Payable days
|
58.42 | 94.44 | -- | -- | 1,383.94 |
|
Cash Conversion Cycle
|
68.68 | -84.42 | -- | -- | -1,771.50 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
